Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:e527
doi: 10.1161/CIRCULATIONAHA.106.636498
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pibarot, P.
Right arrow Articles by Durand, L.-G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pibarot, P.
Right arrow Articles by Durand, L.-G.
Related Collections
Right arrow Valvular heart disease
Right arrow Echocardiography
Right arrow CV surgery: valvular disease

(Circulation. 2006;114:e527.)
© 2006 American Heart Association, Inc.


Correspondence

Response to Letter Regarding Article, "Projected Valve Area at Normal Flow Rate Improves the Assessment of Stenosis Severity in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The Multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) Study"

Philippe Pibarot, DVM, PhD; Claudia Blais, PhD; Jean G. Dumesnil, MD

Research Center of Laval Hospital/Quebec Heart Institute, Laval University, Québec, Canada

Ian G. Burwash, MD; Rob S. Beanlands, MD

University of Ottawa Heart Institute, Ottawa, Canada

Gerald Mundigler, MD; Nicole Loho, MD; Florian Rader, MD; Helmut Baumgartner, MD

Vienna General Hospital (VGH), Medical University of Vienna, Vienna, Austria

Boris Chayer, Eng; Lyes Kadem, Eng, PhD; Damien Garcia, Eng, PhD; Louis-Gilles Durand, Eng, PhD

Institut de Recherches Cliniques de Montréal, Montreal, Canada

We thank Dr Schinkel and colleagues for their comments, with which we are basically in agreement. Indeed, dobutamine stress echocardiography (DSE) in patients with low-flow, low-gradient aortic stenosis (AS) is a serious diagnostic procedure with potential complications. Thus, it should be limited to patients in whom it is likely to influence clinical management.

In this context, it should be remembered that the main objective of DSE is to increase transvalvular flow rate, without inducing myocardial ischemia, to (1) distinguish truly severe AS from pseudosevere AS and (2) assess myocardial contractile reserve. Hence, we agree that a low-dose protocol (ie, up to 20 µg/kg per minute) should be used, as was done in our study.1 In addition, we also prefer longer dobutamine stages (8 minutes instead of the 3 to 5 minutes previously proposed in the literature) to ensure that the patient is in a steady-state condition during Doppler-echo data acquisition and before proceeding to the next stage. The increase in heart rate should also be taken into consideration because it may predispose patients to myocardial ischemia and, at one point, it may override the inotropic effect, thereby limiting the increase in transvalvular flow.

Side effects occurred in 30% of our patients, but these side effects were minor and had no serious clinical consequence. Nonetheless, the point made by Schinkel and colleagues that the occurrence of these side effects may result in premature termination of the test and thereby decrease the diagnostic accuracy of DSE is well taken. However, this disadvantage may be partially or totally counterbalanced by the use of the projected effective orifice area at a normal flow rate, as was demonstrated in our study.

In conclusion, a low-dose gradual DSE protocol with careful monitoring and rigorous end points is safe and may provide important information for clinical decision making and risk stratification in patients with low-flow, low-gradient AS.


*    Acknowledgments
 
Disclosures

None.


*    References
up arrowTop
*References
 

  1. Blais C, Burwash IG, Mundigler G, Dumesnil JG, Loho N, Rader F, Baumgartner H, Beanlands RS, Chayer B, Kadem L, Garcia D, Durand LG, Pibarot P. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation. 2006; 113: 711–721.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pibarot, P.
Right arrow Articles by Durand, L.-G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pibarot, P.
Right arrow Articles by Durand, L.-G.
Related Collections
Right arrow Valvular heart disease
Right arrow Echocardiography
Right arrow CV surgery: valvular disease